Cancer Cell Detection Articles & Analysis
9 news found
Researchers at Dana-Farber Cancer Institute showed that enumeration of circulating tumor cells (CTCs) with Menarini Silicon Biosystems’ CELLSEARCH® System and the CELLSERCH® Circulating Multiple Myeloma Cell (CMMC) Test* can be used to monitor and manage patients with Multiple Myeloma (MM) even at asymptomatic precursor stages ...
Nodexus was selected for an SBIR grant for the development of a novel cancer stem cell detection and isolation platform leveraging the core Nodexus technology ...
New York, United States—April 21, 2022—Defects in mitochondrial function have long been suspected of contributing to the development of cancer. In this regard, Creative Biogene strives to explore mitochondrial functions that are yet to be discovered as well as the pathogenesis of mitochondria-associated cancers and possible interventions through in-depth mitochondrial function testing ...
Combining engineering and medicine can lead to world-leading tools like the Raman spectroscopy, which can help to distinguish cancer cells from healthy cells; for example, in brain tumour surgery.ISTOCKPHOTO / GETTY IMAGES One of the biggest challenges in brain tumour surgery is making sure that all cancer cells ...
The second study involving the Cell-CT™ platform demonstrates the detection of malignancy associated change (MAC) in cancer-associated cells (CACs), without the need to detect actual cancer cells in patients with lung cancer. ...
This is the first study report of VisionGate’s use of its Cell-CT 3D optical computed tomography platform to detect these changes in non-cancerous cells that presumably reside in tumor microenvironment. ...
The cancer cell detection probe developed by Louperivois Frédéric Leblond and Kevin Petrecca, of Polytechnique Montreal and the Montreal Neurological Institute and Hospital, could well be the discovery of the year in Quebec. ...
Dako, an Agilent Technologies company and a worldwide provider of cancer diagnostics, today announced the U.S. Food and Drug Administration (FDA) approval of a new companion diagnostic assay that can reveal whether a patient with advanced non-small cell lung cancer (NSCLC) is likely to respond to a new form of treatment. ...
(NYSE: A) today announced a collaboration with Cell Line Genetics, Inc., a leading provider of cell-line characterization and quality assurance services. ...